Sheng‐Chieh Chou
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hemophilia Treatment and Research
- Genetics top 10%
- Virus-based gene therapy research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 16
- Hemophilia Treatment and Research 10
- Acute Myeloid Leukemia Research 3
- Blood groups and transfusion 2
- Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Chia‐Lun Wu (1 shared paper)Jar‐Yi Ho (1 shared paper)Dah‐Shyong Yü (1 shared paper)Shu‐Wha Lin (6 shared papers)Hwei‐Fang Tien (4 shared papers)Ming Yao (4 shared papers)Yung‐Li Yang (2 shared papers)Jih‐Luh Tang (3 shared papers)
- Journals
- European Journal Of Haematology (2 papers)Haemophilia (2 papers)Blood (2 papers)Research and Practice in Thrombosis and Haemostasis (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- TaiwanUnited StatesGermany
In The Last Decade
Sheng‐Chieh Chou
32 papers receiving 746 citations
Sheng‐Chieh Chou's Hit Papers
Peers
Comparison fields: 5 of 61
- Hematology 439
- Genetics 110
- Cancer Research 98
- Molecular Biology 290
- Genetics 105
Countries citing papers authored by Sheng‐Chieh Chou
This map shows the geographic impact of Sheng‐Chieh Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Chieh Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Chieh Chou more than expected).
Fields of papers citing papers by Sheng‐Chieh Chou
This network shows the impact of papers produced by Sheng‐Chieh Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Chieh Chou. The network helps show where Sheng‐Chieh Chou may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheng‐Chieh Chou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 277 | |
| 2 | Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A Hit paper breakdown → | 2023 | 163 |
| 3 | 2016 | 63 | |
| 4 | 2024 | 39 | |
| 5 | 2016 | 24 | |
| 6 | 2024 | 23 | |
| 7 | 2014 | 22 | |
| 8 | 2016 | 22 | |
| 9 | 2024 | 21 | |
| 10 | 2015 | 17 | |
| 11 | 2022 | 12 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2022 | 9 | |
| 15 | 2018 | 8 | |
| 16 | 2018 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 6 | |
| 20 | 2024 | 4 |
About Sheng‐Chieh Chou
Sheng‐Chieh Chou is a scholar working on Hematology, Genetics, Neurology, Oncology and Cancer Research, having authored 35 papers that have together received 766 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (10 papers), CRISPR and Genetic Engineering (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers), Acute Myeloid Leukemia Research (3 papers), Cerebrospinal fluid and hydrocephalus (2 papers), CAR-T cell therapy research (2 papers), Blood groups and transfusion (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (439 citations), Genetics (110 citations), Cancer Research (98 citations), Molecular Biology (290 citations) and Genetics (105 citations). Sheng‐Chieh Chou has collaborated with scholars based in Taiwan, United States and Germany. Frequent co-authors include Chia‐Lun Wu, Jar‐Yi Ho, Dah‐Shyong Yü, Shu‐Wha Lin, Hwei‐Fang Tien, Ming Yao, Yung‐Li Yang, Jih‐Luh Tang, I‐Shing Yu and Mengni Fan. Their work appears in journals such as European Journal Of Haematology, Haemophilia, Blood, Research and Practice in Thrombosis and Haemostasis and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.